Literature DB >> 19653553

[Complications of the hemodialysis procedure in acute renal failure patients: nursing interventions].

Gabriela Lisangela Della-Flora da Silva1, Elisabeth Gomes da Rocha Thomé.   

Abstract

This retrospective study has identified both the prevalence of complications during hemodialitic treatment in patients carrying acute renal failure (ARF) in an intensive care unit of a university hospital and the nursing conduct performed during those episodes. We have assessed sixty-five (282 sessions) records of ARF patients who underwent renal replacement therapy and presented complications during hemodialysis sessions. We have noticed that the most prevalent intradialitic complications were: arterial hypotension (35%), hypothermia (29%), and lack of flow in the vascular access (24.1%). The nursing interventions prioritized during episodes of clinical complications involved clinical assessment (66.8%) and evaluation of patients' consciousness level (59.9%). The search for nursing procedures that are suitable to different situations experienced by patients during hemodialysis, as well as the continuing education of the nursing team are actions that may minimize the intercurrence rate.

Entities:  

Mesh:

Year:  2009        PMID: 19653553

Source DB:  PubMed          Journal:  Rev Gaucha Enferm        ISSN: 0102-6933


  2 in total

1.  Diagnostic accuracy of the defining characteristics of the excessive fluid volume diagnosis in hemodialysis patients.

Authors:  Maria Isabel da Conceição Dias Fernandes; Miclécia de Melo Bispo; Érida Maria Diniz Leite; Marcos Venícios de Oliveira Lopes; Viviane Martins da Silva; Ana Luisa Brandão de Carvalho Lira
Journal:  Rev Lat Am Enfermagem       Date:  2015 Nov-Dec

2.  Use of non-invasive intracranial pressure pulse waveform to monitor patients with End-Stage Renal Disease (ESRD).

Authors:  Cristiane Rickli; Lais Daiene Cosmoski; Fábio André Dos Santos; Gustavo Henrique Frigieri; Nicollas Nunes Rabelo; Adriana Menegat Schuinski; Sérgio Mascarenhas; José Carlos Rebuglio Vellosa
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.